Research On Drug Patent Linkage

The pharmaceutical industry is closely related to human life and health, survival and development of human diseases appear in the process, the pharmaceutical industry to promote ongoing research. The pharmaceutical industry as a high degree of knowledge and technology intensive industries rely on the patent system to protect. Patent protection gives the market a certain period of drug development are the exclusive rights, access to the corresponding returns, to compensate for its investment in drug research and development stage a lot of time, money, long-term sustainability of drug R & D to keep the source and motivation.Over drug patent protection, may lead to high drug prices beyond the purchasing power of people can afford a threat to public health, protection of drug patents must also be controlled within reasonable limits, drug patents link system design is the purpose and significance balance of pharmaceutical innovation and protect public health, so that generic drugs to market faster to achieve the effect of lower drug prices, raise public awareness of Medicines.Article to the main line of the balance of interests, of the value of drug patents based link system, based on the reference in the analysis and comparison of the United States, Canada, the link system, drug patents, the linkage system of drug patents in China put forward reasonable proposals.Link system of drug patents shortcomings, such as state ownership is not clear and unambiguous instructions; patent affirms is not clear; imperfect handling of patent infringement; Extend the proposed system, the introduction of drug patents, brand-name drugs listed on the application procedure, simplifying application procedures for generic drugs, the grant of a patent challenge generic business market exclusivity, and the proposed national drug regulatory authorities and the patent authorities Departmental communication and coordination, establish an information technology platform, the introduction of generic drug patent infringement risk assessment mechanism, so that the sound development of China's pharmaceutical industry has been.